A possible role for perforin and granzyme B in resveratrol-enhanced radiosensitivity of prostate cancer

J Androl. 2012 Jul-Aug;33(4):752-60. doi: 10.2164/jandrol.111.015164. Epub 2011 Nov 17.

Abstract

Perforin and granzyme B are expressed primarily by activated lymphocytes (cytotoxic T cells, natural killer cells, and natural killer T cells) and function together to induce apoptosis of target cells. Typically, these proteins are not expressed in tumor cells. In the present study, we established the constitutive expression of perforin and granzyme B by the PC-3 and DU145 prostate cancer (PCA) cell lines with reverse transcription polymerase chain reaction, immunohistochemistry, Western blot, or a combination of techniques. The combination of radiation and resveratrol (XRT/RSV) additively/synergistically decreased survival of PCA because, at least in part, of increased apoptosis. We further demonstrated that treatment with RSV up-regulated the expression of both perforin and granzyme B, whereas treatment with XRT up-regulated the expression of granzyme B, but not that of perforin. Combined XRT/RSV treatment of PCA cells further increased the expression of both perforin and granzyme B compared with RSV or XRT alone. Thus, increased radiosensitivity of prostate cancer cells induced by RSV correlated with up-regulation of perforin and granzyme B, demonstrating a possible mechanism for tumor apoptosis. These findings might be helpful in devising new strategies for treating PCA.

MeSH terms

  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Granzymes / physiology*
  • Humans
  • Male
  • Perforin / physiology*
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / radiotherapy*
  • Radiation Tolerance / drug effects*
  • Resveratrol
  • Stilbenes / therapeutic use

Substances

  • Stilbenes
  • Perforin
  • Granzymes
  • Resveratrol